Lee A, Hammond J, Sheridan J, Swift S, Munkacsi A, Villas-Boas S
J Fungi (Basel). 2024; 10(9).
PMID: 39330357
PMC: 11433475.
DOI: 10.3390/jof10090597.
Mohamed E, El-Zahed M
Discov Nano. 2024; 19(1):115.
PMID: 38980559
PMC: 11233486.
DOI: 10.1186/s11671-024-04055-z.
Robi D, Mossie T, Temteme S
Vet Med (Auckl). 2023; 14:195-208.
PMID: 38058381
PMC: 10697087.
DOI: 10.2147/VMRR.S442374.
Shin J, Bae S
Vet Med Sci. 2023; 9(6):2594-2599.
PMID: 37872836
PMC: 10650238.
DOI: 10.1002/vms3.1305.
Romero V, Kalinhoff C, Saa L, Sanchez A
J Fungi (Basel). 2023; 9(9).
PMID: 37755037
PMC: 10532448.
DOI: 10.3390/jof9090929.
Short Review on the Biological Activity of Cyclodextrin-Drug Inclusion Complexes Applicable in Veterinary Therapy.
Grecu M, Minea B, Foia L, Bostanaru-Iliescu A, Miron L, Nastasa V
Molecules. 2023; 28(14).
PMID: 37513437
PMC: 10383344.
DOI: 10.3390/molecules28145565.
Chiral Nano-Liquid Chromatography and Dispersive Liquid-Liquid Microextraction Applied to the Analysis of Antifungal Drugs in Milk.
Dal Bosco C, Bonoli F, Gentili A, Fanali C, DOrazio G
Molecules. 2021; 26(23).
PMID: 34885676
PMC: 8659161.
DOI: 10.3390/molecules26237094.
Selenium nanoparticles from HM1 capable of antagonizing animal pathogenic fungi as a new source from human breast milk.
El-Saadony M, Saad A, Taha T, Najjar A, Zabermawi N, Nader M
Saudi J Biol Sci. 2021; 28(12):6782-6794.
PMID: 34866977
PMC: 8626219.
DOI: 10.1016/j.sjbs.2021.07.059.
Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database.
Li K, Fan J, Qin X, Wei Q
Medicine (Baltimore). 2020; 99(51):e23768.
PMID: 33371142
PMC: 7748316.
DOI: 10.1097/MD.0000000000023768.
Antifungal Resistance Regarding : Where Are We Now?.
Peano A, Johnson E, Chiavassa E, Tizzani P, Guillot J, Pasquetti M
J Fungi (Basel). 2020; 6(2).
PMID: 32630397
PMC: 7345795.
DOI: 10.3390/jof6020093.
Inhibitors of Brassinosteroid Biosynthesis and Signal Transduction.
Rozhon W, Akter S, Fernandez A, Poppenberger B
Molecules. 2019; 24(23).
PMID: 31795392
PMC: 6930552.
DOI: 10.3390/molecules24234372.
Azole resistance of causing treatment failure in a dog.
Angileri M, Pasquetti M, De Lucia M, Peano A
Med Mycol Case Rep. 2019; 23:58-61.
PMID: 30662826
PMC: 6325069.
DOI: 10.1016/j.mmcr.2018.12.004.
Therapy of Non-Dermatophytic Mycoses in Animals.
Elad D
J Fungi (Basel). 2018; 4(4).
PMID: 30380772
PMC: 6308939.
DOI: 10.3390/jof4040120.
Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator-Formulated Itraconazole Capsules and Solution in Healthy Dogs.
Hasbach A, Langlois D, Rosser Jr E, Papich M
J Vet Intern Med. 2017; 31(4):1163-1169.
PMID: 28627123
PMC: 5508362.
DOI: 10.1111/jvim.14779.
Synthesis and Antifungal Evaluation of Novel N-Alkyl Tetra- and Perhydroquinoline Derivatives.
Krauss J, Hornacek M, Muller C, Staudacher V, Stadler M, Bracher F
Sci Pharm. 2016; 83(1):1-14.
PMID: 26839797
PMC: 4727778.
DOI: 10.3797/scipharm.1409-13.
Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole.
Shi C, Liu C, Liu J, Wang Y, Li J, Xiang M
Mycopathologia. 2015; 180(3-4):203-7.
PMID: 25977140
DOI: 10.1007/s11046-015-9899-9.
Discovery of new imidazole derivatives containing the 2,4-dienone motif with broad-spectrum antifungal and antibacterial activity.
Liu C, Shi C, Mao F, Xu Y, Liu J, Wei B
Molecules. 2014; 19(10):15653-72.
PMID: 25268720
PMC: 6271775.
DOI: 10.3390/molecules191015653.
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Vadlapatla R, Patel M, Paturi D, Pal D, Mitra A
Expert Opin Drug Metab Toxicol. 2014; 10(4):561-80.
PMID: 24521092
PMC: 4516223.
DOI: 10.1517/17425255.2014.883379.
CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole.
Nascente P, Meinerz A, de Faria R, Schuch L, Meireles M, de Mello J
Braz J Microbiol. 2013; 40(2):222-6.
PMID: 24031347
PMC: 3769738.
DOI: 10.1590/S1517-83822009000200002.
The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes A, Keniya M, Ivnitski-Steele I, Monk B, Lamping E, Sklar L
Antimicrob Agents Chemother. 2011; 56(3):1508-15.
PMID: 22203607
PMC: 3294898.
DOI: 10.1128/AAC.05706-11.
